Gilead Sciences (NASDAQ:GILD) Downgraded to Buy at StockNews.com

StockNews.com cut shares of Gilead Sciences (NASDAQ:GILD – Free Report) from a strong-buy rating to a buy rating in a report released on Monday. A number of other equities analysts have also commented on GILD. Cantor Fitzgerald dropped their price objective on Gilead Sciences from $80.00 to $78.00 and set a neutral rating on the […]

Leave a Reply

Your email address will not be published.

Previous post Atara Biotherapeutics (NASDAQ:ATRA) Lowered to “Sell” at StockNews.com
Next post Paramount Global (NASDAQ:PARA) Upgraded to “Hold” by StockNews.com